Financials
- Market Capitalization 1.79 B
- Employee 298
- Founded 2005
- CEO N/A
- Website www.syndax.com
- Headquarter Delaware, United States
- FIGI BBG000R33JY1
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-8.71
市销率
7.61
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 2040 | TSHA Taysha Gene Therapies, Inc. - Common Stock | 5.70 USD | +0.18% | -7.32% | -3.23% | +100.70% | 1.86 B USD | ||
| 2048 | INBX Inhibrx Biosciences, Inc. - Common Stock | 124.66 USD | -1.61% | +1.35% | +52.28% | +54.70% | 1.83 B USD | ||
| 2067 | RXRX Recursion Pharmaceuticals, Inc. - Class A Common Stock | 3.33 USD | -2.06% | -4.86% | +9.90% | -29.15% | 1.78 B USD | ||
| 2070 | NTLA Intellia Therapeutics, Inc. - Common Stock | 12.69 USD | -0.31% | -5.16% | +19.83% | -7.51% | 1.78 B USD |